Oligosaccharide System Suitability Mixture D
USP/1478243 - United States Pharmacopeia (USP) Reference Standard
Synonym: N-glycans
Product Type: Chemical
| API family | oligosaccharide sst mixture |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| form | solid |
| format | mixture |
| grade | pharmaceutical primary standard |
| manufacturer/tradename | USP |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Oligosaccharide System Suitability Mixture D reference standard for use in specified quality tests and assays. Also used to prepare AB-labeled standard solutions for liquid chromatographic separation. Additionally, used to separate sialylated bi- and tri-antennary complex N-linked Oligosaccharides with an additional sialic acid on one of the tri-antennary structures. |
| General description: | Oligosaccharide System Suitability Mixture D is a USP reference standard designed to evaluate resolution and performance in oligosaccharide separations. It consists of well-defined carbohydrate structures that aid in the validation of chromatographic systems used in glycan and saccharide analysis. The USP biologics carbohydrates category includes a variety of carbohydrate-based substances that are essential in the development and manufacturing of therapeutic products. These carbohydrates play crucial roles in biological processes and are often utilized as excipients, stabilizers, or active ingredients in pharmaceuticals. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of carbohydrate therapeutics throughout their lifecycle. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of the USP Biologics program. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |